An interventional study of Measles vaccine in Child Mortality and Child Morbidity, sponsored by Bandim Health Project. Completed at 1 site in Guinea-Bissau. Open to participants aged 18 Months to 24 Months, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-01-19.
Sponsored by Bandim Health Project · Not applicable, Interventional, and Prevention
This study evaluates the non-specific effects on child mortality and morbidity of a second dose of measles in the second year of life. Half of the study participants will receive a second dose of measles vaccine at 18 months of age while the other half will receive a second dose of measles by 4 years of age or at the end of the study.
Bandim Health Project is the lead sponsor of 59 studies on the registry; 5 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Measles vaccine, 1 dose of 0.5 ml
Biological: Measles vaccine
Nothing
Mortality
Mortality registered monthly by Health and Demographic Surveillance System fieldworkers. Mortality will be combined with hospital admissions in the analysis to form the outcome severe morbidity. This will be examined overall and by sex
Time frame: 30 months
Hospital admissions
Hospital admissions registered daily at the national hospital. Hospital admissions will be combined with mortality in the analysis to form the outcome severe morbidity. This will be examined overall and by sex
Time frame: 30 months
Hospital admission by cause
Causes of hospital admissions registered daily at the national hospital. These will be examined overall and by sex
Time frame: 30 months
Consultations
Consultations registered daily at the local health centers and the national hospital. These will be examined overall and by sex
Time frame: 30 months
Plan to share: No
This study is completed, as verified in Jan 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drug tested here: Measles Vaccine
Bandim Health Project